Evaluation of Sustained-Release Steroid Hydrogels in a Guinea Pig Model for Noise-Induced Hearing Loss

Audiol Neurootol. 2018;23(2):73-81. doi: 10.1159/000487662. Epub 2018 Aug 9.

Abstract

The otoprotective effects of thermoreversible poloxamer 407 hydrogels containing dexamethasone or triamcinolone acetonide were evaluated in an animal model of noise-induced hearing loss. Seven days after noise exposure, hearing threshold shifts at 16 kHz were significantly reduced in the 6% dexamethasone group (p < 0.05). Even though no significant differences in hair cell counts were found, histological analysis revealed a significantly higher spiral ganglion cell density in the first turn of the cochlea in this group (p < 0.05). No otoprotective effects were observed after the application of the triamcinolone acetonide hydrogels. As the findings of this study indicate potential otoprotective effects of sustained topical dexamethasone delivery in the setting of noise-induced hearing loss, this strategy merits further evaluation.

Keywords: Dexamethasone; Intratympanic glucocorticoids; Noise-induced hearing loss; Poloxamer 407; Triamcinolone acetonide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Auditory Threshold / drug effects
  • Cochlea / drug effects
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / therapeutic use*
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use*
  • Disease Models, Animal
  • Female
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use*
  • Guinea Pigs
  • Hearing / drug effects
  • Hearing Loss, Noise-Induced / drug therapy*
  • Hydrogels / administration & dosage
  • Hydrogels / therapeutic use*
  • Male
  • Triamcinolone Acetonide / administration & dosage
  • Triamcinolone Acetonide / therapeutic use*

Substances

  • Delayed-Action Preparations
  • Glucocorticoids
  • Hydrogels
  • Dexamethasone
  • Triamcinolone Acetonide